QuantaMatrix Inc.

QuantaMatrix Inc. is an in-vitro diagnostics company based in Seoul, South Korea, founded in 2010. Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic testing directly from positive blood culture; QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis; QPLEX Alz plus assay, an early diagnosis kit for Alzheimer's disease; and Quanti9 and QuantiGal, prognostic prediction kits for cardiovascular diseases.